PMV Pharmaceuticals, Inc

PMVPNASDAQUSD
1.31 USD
0.00 (0.00%)AT CLOSE (11:59 AM EDT)
1.31
0.01 (0.69%)
POST MARKET (AS OF 05:32 PM EDT)
Post Market
AS OF 05:32 PM EDT
1.31
0.01 (0.69%)
🟢Market: OPEN

PMVP is currently priced at $1.31. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Aug 25, 2026.

Open?$1.31
High?$1.32
Low?$1.29
Prev. Close?$1.31
Volume?211.7K
Avg. Volume?314.6K
VWAP?$1.31
Rel. Volume?0.67x
Bid / Ask
Bid?$1.07 × 100
Ask?$1.53 × 100
Spread?$0.46
Midpoint?$1.30
Valuation & Ratios
Market Cap?70.0M
Shares Out?53.5M
Float?43.6M
Float %?81.7%
P/E Ratio?N/A
P/B Ratio?0.98
EPS?-$1.41
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
Employees
54
Market Cap
69.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-09-25
Address
400 ALEXANDER PARK DRIVE
PRINCETON, NJ 08540
Phone: (609) 642-6670
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
54
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.42Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?5.15%Elevated
Short Interest?2.2M
Days to Cover?5.9
Free Float43.6M
Avg Daily Volume379.0K
Settlement Date2026-08-14
Financial Health
Current Ratio?7.70Strong
Quick Ratio?7.70Strong
Cash Ratio?1.18Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.98CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.7CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-105.2%WEAK
ROA?
S&P
3
-91.7%WEAK
Cash Flow & Enterprise
FCF?$-71279000
Enterprise Value?$57.6M
Fundamentals ratios updated end of day